CommercialCoverageLow impact
Tonic Motor Activation for Restless Legs Syndrome (1.01.32)
Blue Shield of California·CA · Neurology, Sleep Medicine·Medical Policy
Effective date
Mar 1, 2026
We identified it
Mar 1, 2026
Summary
Blue Shield of California has established a new medical policy classifying Tonic Motor Activation (TOMAC) for restless legs syndrome as investigational and therefore not covered. This affects the NTX100 TOMAC System, a peroneal nerve stimulation device for patients with medication-refractory restless legs syndrome.
Action Required
By March 1, 2026: Billing team must update prior authorization system to deny coverage for Tonic Motor Activation (TOMAC) procedures for restless legs syndrome treatment. Update billing software to flag these services as investigational/non-covered for Blue Shield of California members. Notify providers that claims for TOMAC will be denied as investigational.